Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents. It is characterized by highly complex karyotypes with structural and numerical chromosomal alterations. The observed OS-specific characteristics in localization and frequencies of chromosomal breakages strongly implicate a specific set of responsible driver genes or a specific mechanism of fragility induction. In this study, a comprehensive assessment of somatic copy number alterations (SCNAs) was performed in 160 OS samples using whole-genome CytoScan High Density arrays (Affymetrix, Santa Clara, CA). Genes or regions frequently targeted by SCNAs were identified. Breakage analysis revealed OS specific unstable regions in which wellknown OS tumor suppressor genes, including TP53, RB1, WWOX, DLG2 and LSAMP are located. Certain genomic features, such as transposable elements and non-B DNA-forming motifs were found to be significantly enriched in the vicinity of chromosomal breakage sites. A complex breakage pattern-chromothripsis-has been suggested as a widespread phenomenon in OS. It was further demonstrated that hyperploidy and in particular chromothripsis were strongly correlated with OS patient clinical outcome. The revealed OS-specific fragility pattern provides novel clues for understanding the biology of OS.
rates reach 60%, 6 but have plateaued during the past decades. Further improvement in cure rates will most likely depend on an increased knowledge about the underlying molecular mechanisms of this disease.
Although several predictors, such as gene expression profiles 7 and chromosomal alteration staging systems 4 have been proposed to anticipate tumor response to chemotherapy, common markers of prognostic and therapeutic value remain to be identified. Genomic instability, a hallmark of most cancers, including OS, 8, 9 is either driven by positive selection or originates from sequence-specific unstable regions. 8 Chromosomal fragile sites are specific genomic locations that appear as gaps or breaks on metaphase chromosomes under replication stress. 10 This can be induced by endogenous or exogenous sources, and result in the generation of DNA double strand breaks (DSBs) and genomic instability. 11 A variety of molecular pathways are involved in DSB repair, and, in the case of deficient repair, copy number alterations result.
To identify SCNAs, array-based copy number profiling has been used as an alternative to next generation sequencing due to its lower consumption of precious biopsy material. DNA copy number profiling was generally opted for over gene expression, as it provided relatively stable profiles enabling differentiation of clinically relevant genetic subgroups. 12 However, the analysis of whole genome array data for tumor samples can be difficult due to the fact that the total DNA amount in a cancer cell can differ significantly from a diploid state, and tumor tissues often contain some proportion of normal cells. 13 SCNAs have the potential to inactivate tumor suppressor genes or activate oncogenes, and consequently play fundamental roles in gene regulation and pathobiological processes in cancer. 14 Analyses of SCNA data generated in recent years have provided insights into driver genes for many tumor types. 14, 15 However, the enormous complexity of genomic aberrations in OS has made it challenging to identify recurrent alterations and genes driving tumorigenesis. 3, 5 Furthermore, in OS the identification of driver genes has been hindered by intratumor and intertumor heterogeneity and limited sample availability. 5, [16] [17] [18] Despite such complications, we and others have revealed recurrent genomic loss in regions containing tumor suppressor genes such as LSAMP, CDK2NA, RB1 and TP53 and most frequent gains at sites including the oncogene MYC and the gene RUNX2-an important player in osteogenic differentiation. 5, [16] [17] [18] [19] Apart from their genomic instability, OSs show a disease specific SCNA pattern. The phenomenon of chromothripsis represents an important mechanism of carcinogenesis that differs from progressive accumulation of genomic rearrangements. The simultaneous fragmentation of distinct chromosomal regions (breakpoints showing a specific, nonrandom distribution) and subsequent imperfect reassembly of those fragments leads to a specific SCNA pattern (chromothripsis like pattern, CTLP). The initial discovery indicated that chromothripsis is a widespread phenomenon, which can be seen in 2-3% of all cancers, most notably in 25% of bone cancers. 20 There is strong evidence for an association between chromothripsis and poor outcome in different cancer types, including multiple myeloma, 21 neuroblastoma 22 and Sonic-Hedgehog medulloblastoma. 23 Although the mechanisms governing chromothripsis are largely unknown, it has important implications for our understanding of cancer and disease, 24 as such detailed analyses of CTLPs may shed light on OS development and progression. Herein, copy number profiles derived from 160 pretherapeutic OS biopsies have been analysed using wholegenome CytoScan High Density (CytoScan HD) arrays (Affymetrix, Santa Clara, CA). Integration of SCNAs for each sample was performed in order to identify potential genes driving OS oncogenesis. Previously found OS driver genes were identified as well as other OS-related genes. Chromosomal breakages were found to be spatially clustered in certain locations, termed "broken regions", harboring the regarded OS tumor suppressor genes TP53, RB1, WWOX, DLG2 and LSAMP. Furthermore, chromosomal breakages in these regions occurred early and were influenced by local genomic context. Most noteworthy, both aneuploidy and CTLP occurrence were found to be correlated with clinical outcome of OS patients.
Methods

Tissue samples and patient characteristics
For CytoScan HD array analysis, a set of 160 fresh-frozen tissue samples derived from pretherapeutic biopsies was used. All biopsies were evaluated by an experienced bone pathologist who confirmed the tumor content to be >70% per sample. The patient cohort samples were obtained according to the guidelines and approval of the Research Ethics Board at What's new? Osteosarcoma (OS) is characterized by highly complex karyotypes with structural and numerical chromosomal alterations. The observed OS-specific characteristics in localization and frequencies of chromosomal breakages implicate a specific set of responsible driver genes or specific mechanism of fragility induction. Here, a comprehensive assessment of somatic copy number alterations (SCNAs) was performed in 160 OS samples. Breakage analysis revealed OS specific unstable regions in which well-known OS tumor suppressor genes, including TP53, RB1, WWOX, DLG2 and LSAMP are located. A complex breakage pattern-chromothripsis-was suggested as a widespread phenomenon in OS and found to be predictive of patient clinical outcome.
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Smida et al. Table S1 ) were based on true diploid regions in individual tumor samples (performed using Nexus with subsequent manual curation by experts from BioDiscovery, Inc.). SCNAs with fewer than 20 informative probes were excluded from further consideration. GISTIC 2.0 (Genomic Identification of Significant Targets In Cancer) integrated in the Nexus copy number software was utilised to identify potential driver SCNAs and genes by evaluating the frequency and amplitude of observed events. 27 Subclone structures were reconstructed for each tumor sample based on SCNA calling data from Nexus copy number software. The SubcloneSeeker software 28 was used to decompose tumor subclone structures. In this study, a subclone was defined as a collection of cells in the tumor sample that contained the same set of SCNAs. The segmental mean values of each segment generated by SNP-FASST2 was used as input for the SubcloneSeeker software 28 to reconstruct the clonal structures for each patient. The segtxt2db and ssmain applications were employed to cluster the segments based on their cell prevalence values and to enumerate the clonal structures. The results were exported using the "treeprint" utility. We refer to the SCNAs that occurred at the root node of the subclone tree as "clonal" SCNAs and to all others as "subclonal".
Definitions of chromosomal breakages and their association with genomic features
We defined genomic starts and ends of SCNAs as SCNA breakpoints although their exact chromosomal positions could not be determined. Breakpoints situated upstream of the first or downstream of the last CytoScan HD probe on the same chromosome as well as those located in telomeres or centromeres were ignored. We defined a genomic position to be a chromosomal break when the Log 2 signal value alteration between two adjacent genomic segments (from centromere to telomere) was > 0.3.
An association was determined between chromosomal breakages and multiple genomic features as obtained from public databases and published studies or as identified in the current study. All genomic coordinates of the features correspond to the human genome assembly hg19 and, when necessary, the University of California, Santa Cruz (UCSC) liftOver tool was used to convert the hg18 coordinates to hg19. 29 Specifically, chromosomal coordinates for Alu repeats, DNA transposons, L1 and long terminal repeat (LTR) 29 Non-B DNA motifs were obtained from non-B DB v2.0. 30 Common fragile sites were found to be tissue-and cell-type specific. 31 As tissue-specific data was not available, we obtained genomic coordinates for common fragile sites and non-fragile regions from a previous study. 32 We defined nucleotide substitution (or insertions/deletions, indels) rate as the ratio of the total number of substitutions (or indels) to the total number of nucleotides in the human-chimpanzee alignments (from UCSC Genome Browser).
The density of SCNA breakpoints, chromosomal breaks or genomic features (i.e., item) were defined as the ratio of total base pairs belonging to the item against the total length of the genomic region. The subdivision of the genome, shuffling and feature density calculation were performed using BEDTools 33 and in-house Perl scripts.
Detection of CTLPs in OS
To detect CTLPs the algorithm described in 34 was applied to identify clustering of copy number changes in the genome. Default settings were used except for the parameter of Log 2 signal value difference between two adjacent segments (set to 0.2). CTLP samples were determined by the evidence of the copy number switching its status at least 12 times (SwitchNo 12) and Log 10 of likelihood ratio >8 (Log 10 LR 8) within a single chromosome.
Estimation of tumor purity and ploidy
SNP-based DNA microarrays allow simultaneous measurement of the allele-specific copy number at many different SNP loci in the genome. For each probeset, the log R ratio (LRR) reflects the ratio of total signal intensity for both alleles against expected signals, and the B allele frequency (BAF) is an estimate of the relative proportion of one of the alleles with respect to the total signal intensity. LRR and BAF values were derived using the affy2sv R package 35 together with the Affymetrix Power Tools. A total of 873 normal samples downloaded from the study 36 (Gene Expression Omnibus accession number: GSE59150) were also processed using affy2sv. The resulting LRR and BAF were used as input for the GPHMM algorithm (version 1.4) 37 to obtain an estimation of normal cell contamination and absolute copy number of genomic segments for each sample. Population frequency of the B allele file required for running GPHMM was created using the Perl script compile_pfb.pl in PennCNV, 38 with BAF values from the 873 normal samples as input. Another required file-GC model file (GC content flanking SNP markers)-was generated using the Perl script cal_gc_snp.pl in PennCNV. 38 Tumor ploidy was further determined following the protocol described in. 39 Specifically, the chromosome arm count in a tumor genome was estimated based on the absolute copy number of genomic segments in the pericentric region. The copy number of the corresponding arm was set to the absolute copy number of the segments in the pericentric region if its size was 1.5 Mb. Otherwise, if the size of the pericentric segments was < 1.5 Mb, the copy number of the chromosome arm was approximated by the average copy number of all segments on that chromosome arm. Tumor ploidy was assigned for each tumor sample based on chromosome counts and the DNA index, defined as the average copy number of the tumor genome divided by 2. Tumor ploidy was set at 2 (near-diploid genome) for chromosome counts < 60 and DNA index < 1.3, and set at 4 (near-tetraploid genome) for chromosome counts 60 and DNA index 1.3. 40 
Results
Overview of SCNAs in OS
The SCNA landscape of pre-treatment tissue samples (n 5 160) from OS patients (characteristics of whom are provided in Table 1 ) was profiled using Affymetrix CytoScan HD arrays. Three samples were excluded from copy number analysis due to insufficient data quality. A genome-wide frequency plot of SCNAs is shown in Figure 1 . In our collections, the median size of the SCNAs was 1.2 Mb with the OS genome having on average 209 SCNA events. Regional gains and losses of various sizes were observed, ranging from entire chromosomes to minor genomic segments. Many oncogenes and tumor suppressor genes were located within these sites. No significant correlation was noted between the total SCNA number, size or median in relation to age or gender. An apparent correlation trend was evident for total SCNA size and survival, although perhaps due to insufficient power this did not reach significance.
GISTIC analysis and tumor subclone decomposition uncover key driver genes affected by SCNAs in OS GISTIC 2.0 27 is a tool to identify genes targeted by SCNAs that may drive cancer development. The X and Y chromosomes were excluded from the analysis and were analysed separately in gender specific subsets of OS patients. GISTIC identified 88 regions significantly altered in 157 OS samples ( Fig. 2 ; genomic locations of these regions are listed in Supporting Information Table S2 ). The annotation of GISTIC regions revealed 101 targeted genes (listed in Supporting Information Table S3 ), of which the vast majority (74 transcripts) were protein-coding genes. Nine genes listed in the Catalogue of Somatic Mutations in Cancer (COSMIC) Cancer Gene Census (CGC) 41 -namely NOTCH2, PDGFRA, CDK4, CCNE1 and RUNX1 were located in copy-number gain regions, while CDKN2A, FLI1, TP53 and ATRX were identified in copy-number loss regions. TP53 and ATRX, often targeted by SCNAs, have been reported by us and others as important driver genes in OS. 16, 42, 43 Besides these wellknown OS driver genes, GISTIC regions contained several other OS-related genes, such as RUNX2 and DLG2. 16, 44 Analysis also revealed novel or recently described genes-FOXN1 and WWOX. FOXN1 (17q11.2) is the main transcriptional regulator of thymic epithelial cell development, differentiation and function. 45 Although it directly or indirectly regulates expression of a broad variety of genes, it has not been found to Tumor Markers and Signatures Smida et al. date associated with cancer and, in particular OS. The WWOX gene (16q23.1) spans a common fragile site FRA16D, associated with DNA instability in cancer. 46 Recently, a series of reports demonstrated the relevance of reduced or absent WWOX expression in various cancer types, including OS, presumably due to chromosomal deletions and translocations within the WWOX gene, highlighting an essential role for WWOX in tumor suppression and genomic stability. [47] [48] [49] Besides, the tumor suppressor and pro-apoptotic activity of WWOX in OS, its role in osteogenic differentiation and interaction with RUNX2 has recently been elucidated. 50 A malignant tumor often consists of genetically distinct cell populations, referred to as tumor sub-clones, with each possessing a specific mutation subset. Determination of the order in which SCNA mutations occur is a powerful means for identifying genes with fundamental roles in oncogenesis. SubcloneSeeker 28 succeeded in inferring subclone structures for 99.4% of tumors (156 out of 157). The mean number of predicted subclone structures for each tumor was 8.5 (ranging from 1 to 45, Supporting Information Table S4 ). Thirtysix tumors had >10 possible subclone structures, which may be due to the complex nature of such tumor samples. Next, an investigation was undertaken as to whether or not SCNAs overlapping with putative genes (identified by GISTIC) were clonal events. Previously reported findings as revealed by alternative approaches were confirmed, to show that even for the well-known OS driver genes such as TP53 and RB1, the majority (90%) of SCNAs were subclonal events. 43 Thirtyfour tumors had clonal SCNAs overlapping 1-10 driver genes, such as TP53, RB1, DLG2, WWOX, TERT, FOXN1, APC, PTEN, LSAMP, ATRX and CDKN2A. No single gene had clonal SCNAs in the majority of tumors.
Breakage analyses reveal OS-specific unstable regions
DNA breakage is a prerequisite for cancer-associated genomic aberrations, including amplifications, deletions, inversions, and translocations. The genomic start and end of SCNAs were defined as breakpoints with a precision of 1 kb (average interprobe distance for CytoScan HD Array is < 1 kb). Since whole genome arrays have reduced ability for inversion and/or translocation detection, the chromosomal breakage landscape was investigated, which strongly indicated the prevalence of genomic rearrangements. The criterion for considering a SCNA breakpoint as a chromosomal break was based on the Log 2 signal value alteration between two adjacent genomic segments > 0.3 (Supporting Information Fig. S1 ), which is more stringent than the cutoff of 0.23 previously used. 51 In total, 62,172 SCNA breakpoints and 19,810 chromosomal breaks were identified in 157 OS samples. The number of chromosomal breaks per sample ranged from 17 to 425, with a median value of 114. The number Table  S5 ) were significantly enriched for chromosomal breaks (Bonferroni corrected p-values < 0.1). Out of these "broken regions", 11% are located within common fragile sites, while 46% overlapped with non-fragile sites, 32 indicating apparent OSspecific instability characteristics.
Some of the OS-associated tumor suppressor genes, 19 including TP53, RB1, WWOX, DLG2 and LSAMP, but no known OS oncogenes, were located in these broken regions (Fig. 3) . To determine the evolutionary order in which SCNAs occurred in these areas, a comparison was made with clonal SCNAs obtained by the SubcloneSeeker analysis. An enrichment of clonal SCNAs was found in these broken regions compared to randomly generated ones (10,662 vs. 4579, p-value 5 0), implicating chromosomal breakage as a clonal event of early occurrence in tumorigenesis.
To identify genes prone to breakage in OS, we compared the distribution of actual chromosomal breaks to a background distribution obtained by shuffling the position of chromosomal breaks 1,000 times. This approach, while limited by a degree of uncertainty in calling the location of chromosomal breaks (due to the inter-probe distance characteristic of CytoScan HD arrays), can nevertheless provide clues as to which genes are prone to breakage in OS. A total of 343 genes were found to harbor chromosomal breaks significantly more frequently than would be expected by chance (Bonferroni corrected p-values < 0.01). Of these, 24 genes (listed in Table 2 ) have been previously shown to be associated with OS (DLG2, WWOX, TP53, RB1, LSAMP, PTEN and APC
19
) and other tumors (DMD, EYA1, SCAPER, WNK1, KANSL1, TP63, FOXN1 and CHM) and found by GISTIC analysis. TP53 was selected to demonstrate the distribution of chromosomal breaks along the gene. As seen in Supporting Information Figure S2 the largest number of chromosomal breaks was located in the first intron of this gene. 16, 42 Chromosomal breakage in OS is dependent on local genomic context To examine whether chromosomal breakages in OS were associated with the local genomic context, we investigated the Figure 3 . The genomic landscape of chromosomal breaks and associated genes in OS. The outermost circle represents chromosomes and cytogenetic bands. The next circle represents known OS driver genes and other genes as listed in Table 2 . The third circle represents "broken regions." The innermost circle shows common fragile sites and non-fragile regions in red and blue, respectively. [Color figure can be viewed at wileyonlinelibrary.com] joint distributions of chromosomal breaks, SCNA breakpoints and multiple genomic features within a 1 Mb genomic window. Previous studies have shown that DNA breakage can be induced by DNA structures such as non-B DNA conformations, including Cruciform, G-quadruplexes (G4), Slip, Triplex, and Z-DNA, and by highly homologous genomic repeats, such as L1 and Alu. [52] [53] [54] Further features considered in this analysis were common fragile sites, evolutionarily conserved elements, substitution rate, indel rate and exon density which have been associated with SCNA breakpoints. 53, 55, 56 As expected, SCNA breakpoints and chromosomal breakage are highly correlated (p-values < 2.20 3 10
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, Spearman rho 5 0.76). In addition, it was also noted that SCNA breakpoints and chromosomal breaks were significantly correlated with diverse genomic properties, including Alu, L1, Cruciform, G4, Slip, Triplex, Z-DNA, exon density and indel rate (Bonferroni corrected p-values < 0.01; Supporting Information Table S6 ).
We further examined the association of genomic properties to chromosomal breaks at a higher resolution. Specifically, windows of 10, 20, 50 and 100 kb centred around each chromosomal break were analysed with subsequently merging of overlapped windows. The density of each feature was computed and determined as to whether the feature was enriched compared to the remaining regions. Compared with random expectation, the vicinity of chromosomal breaks was significantly enriched for several genomic features, including genomic repeats, non-B DNA conformation forming motifs, conserved elements, exon density, substitution rate and indel rate (Table 3 ; Bonferroni corrected p-values < 0.01, MannWhitney test). These genomic features have been associated with SCNA breakpoints in different cancer types, 55 suggesting that OS is similar to other cancers in regards to chromosomal breakage occurrence. Of note, common fragile sites were not preferentially associated with chromosomal breaks at any genomic resolution investigated in this study ( Table  3 ), indicating that OS has perhaps very specific breakage characteristics that include already known common fragile sites as well as unique sites of instability.
Clinical implications of CTLPs and hyperploidy
Applying the CTLP detecting algorithm to the OS SCNA dataset, a total of 87 chromosomes from 52 patients passed All genomic coordinates are based on human genome assembly hg19; Count: the total number of chromosomal breaks found in gene regions; % OS: percent of OS samples affected by chromosomal breaks; gene names previously associated with OS 19 are in bold; gene names identified by GISTIC analysis in this study are in italics.
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the threshold and were termed CTLP cases. CTLP occurred in 33.1% of patients within this dataset, implying that chromothripsis is a widespread phenomenon in OS. This incidence rate was largely consistent with a previous study of a small sample size of bone cancers. 20 CTLPs had a tendency to occur frequently on chromosomes 8 (11.5%) and 17 (9.2%). The OncoPrint shown in Figure 4 provides an overview of SCNAs in specific genes and CTLP affecting individual samples. Chromosomal aberrations in TP53 occurred in 88% (46/52) of CTLP patients, compared to 56% (59/105) of non-CTLP cases (p-value 5 1.0 3 10
24
, two-tailed Fisher's exact test). We analyzed three genes-RB1, WWOX and DLG2-that frequently harbor structural variation in OS. 16 Chromosomal alterations in RB1 occur in 73% (38/52) of CTLP cases, but only in 48% (50/105) of non-CTLP samples (p-value 5 3.5 3 10
23
, two-tailed fisher's exact test). Chromosomal aberrations in WWOX occur in 85% (44/52) and 66% (69/105) CTLP and non-CTLP samples respectively (p-value 5 1.4 3 10
22
, two-tailed fisher's exact test). Finally, 83% (43/52) of CTLP cases harbored aberrations in DLG2, compared with 57% (60/105) of non-CTLP cases (p-value 5 1.3 3 10
23
, two-tailed fisher's exact test). These observations indicate that chromosomal aberrations in TP53, RB1, WWOX and DLG2 genes are strongly associated with CTLPs in OS.
Furthermore, an investigation of the association between CTLPs and clinical data was performed. 57 As follow-up clinical data was available for 114 patients, CTLP was detected in 33% (38/114) of this cohort. Notably, as shown in Figure 5a , Kaplan-Meier analysis revealed that patients with CTLP patterns in their tumors showed significantly curtained survival 
Common fragile sites expectancies compared to those without CTLP (log-rank test, p-value 5 7.06 3 10 24 ). A successful estimation was made of tumor ploidy and content for 90.4% (142/157) of samples using the GPHMM algorithm. These OS biopsies were estimated to have on average 37.5% normal tissue contamination with a median ploidy of 2.7n. Following the procedures for chromosome number estimation (as described in the "Methods"), the distribution of chromosome numbers was plotted in 142 samples to clearly demonstrate a two ploidy status of the tumor genome (Fig. 5b) . Near-diploid was defined for tumors with chromosome number < 60 and DNA index <1.3 (see "Methods" for details), without consideration for SCNAs presence or absence in tumors. Near-tetraploid tumors had greater chromothripsis events than those classified as near-diploid (Fig. 5c, p- 58 Patients with tumors exhibiting near-tetraploid genomes had poorer survival compared with patients having tumors with estimated ploidy of 2 ( Fig. 5d) .
Discussion
Rarity and genomic complexity, as well as marked intratumoral and intertumoral heterogeneity, have challenged the molecular characterization of OS etiology. 19 Given the difficulty in acquiring a large cohort of samples in this rare tumor, we integrated DNA copy number profiles of 160 pretherapeutic biopsies to identify recurrent genomic changes and driver genes. Genome-wide profiles were performed using an Affymetrix CytoScan HD platform, which has the highest resolution of SNP and nonpolymorphic probes for detecting human chromosomal alterations. Copy number analyses confirmed high genomic instability in OS biopsies, with the vast majority of samples (82%) exhibiting highly complex altered genomes. The unstable genome in the majority of OS is probably due to the deficiency in homologous recombination repair. 43 The 
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BRCA1/2 (important players in homologous recombination pathway) deficiency associated characteristics in single base substitutions, and large-scale genome instability signatures are evident in >80% of OS. 43 Using GISTIC, we identified a number of genes frequently targeted in OS, including already known driver genes (e.g., TP53 and ATRX) as well as other OS-related genes, such as WWOX. WWOX is a putative tumor suppressor gene encompassing a common fragile site FRA16D, which is a frequent target of chromosomal rearrangement in multiple cancers. The absence or reduced expression of WWOX have been linked to poor prognosis in a wide variety of cancers, particularly in ovarian cancer and OS. 59, 60 In previous reports by others, the function loss of WWOX has been linked to chromosomal deletions and translocations as well as loss of expression. 47, 49 In this study, we showed that 32% of OS samples have at least one chromosomal break within the WWOX gene, supporting the WWOX inactivation by chromosomal rearrangements. We further showed that the WWOX gene was located in "broken regions" (discussed below) with SCNAs and chromosomal breaks in those regions more likely to be of early occurrence. These results are consistent with the hypothesis that loss of WWOX expression is an early event in OS pathogenesis. 49 Genome-wide analysis revealed that chromosomal breaks are not randomly distributed and clustered in "broken regions". About half of these regions overlapped with nonfragile sites, strongly suggestive of OS-specific fragility. Our observations comply with the findings that unstable sites are tissue specific. 31 It is noteworthy that OS-associated tumor suppressor genes including TP53, RB1, WWOX, DLG2 and LSAMP 19 are situated in "broken regions". SCNAs in those regions were more likely to be clonal events as opposed to those expected by chance. The early occurrence of breakages and the presence of multiple tumor suppressor genes in such regions may explain the complex and aggressive nature of OS.
We further revealed that SCNA breakpoints and chromosomal breaks were significantly correlated with diverse genomic properties, including Alu, L1, cruciform, G4, slip, triplex, Z-DNA, conserved elements, exon density, and indel rate. Genomic repeats such as L1 and Alu are interspersed throughout the human genome at high copy numbers, and non-allelic homologous recombination events between different copies lead to duplications, deletions, and inversions. 61 Repetitive DNA motifs may fold into non-B DNA conformation, thereby serving as chromosomal targets for DNA repair and recombination leading to the formation of structural variations including CNVs, inversions and translocations. 62 Therefore, it could be speculated that breakages probably occur at OS-specific instability sites with the potential to form stable secondary structures (i.e., non-B DNA structures) and to consequently stall the replication fork.
Based on 20 patients including 9 OSs and 11 chordomas, Stephens et al. 20 estimated that 25% of bone cancers were associated with chromothripsis. In our dataset, CTLPs occurred in about one third of patients suggestive that chromothripsis is a widespread OS phenomenon. Massive genomic rearrangement raised by chromothripsis apparently represents an important mechanism of carcinogenesis, as distinct from progressive accumulation. Although the underlying cause of chromothripsis is not fully understood, several hypotheses have been recently proposed. 20, 63, 64 Firstly, chromothripsis might occur by ionizing radiation induced DNA damage at a short or long stretch of the chromosome. 20, 63 Secondly, telomere attrition may cause dicentric chromosomes which persist through mitosis developing into chromatin bridges that further generate single-stranded DNA and trigger DNA repair. 20, 65 Thirdly, abortive apoptosis has also been considered as a possible mechanism, 63 but it does not provide a reasonable explanation for the localization of DNA shattering. 64 Fourthly, premature chromosome compaction, in which chromosomes are induced to undergo chromosome condensation before completing DNA replication, results in shattering of the incompletely replicated chromosome. 66 An appealing explanation for chromothripsis is that the localized damage could occur in one or two chromosomes (or chromosome part) physically isolated from other chromosomes. 67 The so-called nuclear structure "micronuclei" are widely observed in cancer cell lines. Taking advantage of live cell imaging and single-cell genome sequencing, Zhang et al. demonstrated that chromatid fragmentation and subsequent reassembly occur in the micronucleus and can generate localized genomic rearrangements, some of which recapitulate all features of chromothripsis. 68 Investigation of the association between lesions in specific genes and chromothripsis will offer some insights into the impact of chromothripsis in cancerogenesis. Our analysis indicates that SCNAs in the TP53, RB1 and DLG2 are strongly associated with CTLPs in OS. Among them, DLG2 frequently shows breakages in OS and may be a preferential target for chromothripsis and breakage. 16 RB1 is significantly copy-number altered in OS, while the other candidate, TP53, has already been linked to chromothripsis in medulloblastoma. 23 Utilizing an in vitro cell-based system, chromothripsis has been recently linked to hyperploidy. 58 Indeed, we have shown that compared with diploid tumors, those which are hyperploid had a greater chance to harbour chromothripsis events and less favourable outcomes.
Conclusions
A comprehensive characterization of SCNAs in a large cohort (n 5 160) of OS samples was undertaken in this study. Almost all (98%) of the analysed OS samples were of sufficient quality for data analysis. A high degree of aneuploidy and large-scale copy number alterations in OS were confirmed. Using GISTIC, a number of genes that are frequently targeted in OS were identified, of which TP53, ATRX, FOXN1 and WWOX are already known tumor suppressors associated with OS and other tumor types. Genome-wide analysis of chromosomal breaks revealed a tendency for confinement to genomic regions harbouring OS-associated tumor suppressor genes including TP53, RB1, WWOX, DLG2 and LSAMP. Breakage susceptibility in OS was found to be largely dependent on local genomic context. A complex breakage pattern-chromothripsis-is suggested as a widespread OS phenomenon correlated with patient survival. By unlocking a definitive OS instability pattern, a specific code is hereby revealed shedding an important light on the biology of OS.
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